Phase III study of a nicotine vaccine for smoking cessation
Ended Project Grant Awarded Last action
- Award ID
- RC2DA028837
- Recipient
-
Nabi Biopharmaceuticals UEI DK92BKNVVVB9
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $10,007,124
Award facts
- Assistance listing
- 93.701 Trans-NIH Recovery Act Research Support
- Completion date
- Place of performance
- North Bethesda, MD 20852, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $1,565,470 | |
| Amendment | $500,000 | |
| Amendment | $500,000 | |
| Original award | $7,441,654 |
Quick answers
Who received award RC2DA028837?
RC2DA028837 was awarded to Nabi Biopharmaceuticals by National Institutes of Health (Department of Health and Human Services) on September 30, 2009.
How much is award RC2DA028837 worth?
$10,007,124 has been obligated on RC2DA028837.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award